Nephrotoxicity and Interstitial Nephritis Caused by Drugs and Toxins
By:
Florent Von Tokarski Department of Nephrology, Dialysis, and Transplantation, Foch Hospital, F-92150 Suresnes, France

Faculty of Medical School, University of Paris Saclay/Versailles, Montigny-Le-Bretonneux, France

Search for other papers by Florent Von Tokarski in
Current site
Google Scholar
PubMed
Close
and
Alexandre Hertig Department of Nephrology, Dialysis, and Transplantation, Foch Hospital, F-92150 Suresnes, France

Faculty of Medical School, University of Paris Saclay/Versailles, Montigny-Le-Bretonneux, France

Search for other papers by Alexandre Hertig in
Current site
Google Scholar
PubMed
Close
  • Collapse
  • Expand
  • 1.

    Hales CM, Kohen D. Prescription drug use among adults aged 40–79 in the United States and Canada. NCHS Data Brief. Available at: https://www.cdc.gov/nchs/products/databriefs/db347.htm. Accessed August, 2019.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Liu C, Yan S, Wang Y, Wang J, Fu X, Song H, et al.: Drug-induced hospital-acquired acute kidney injury in China: A multicenter cross-sectional survey. Kidney Dis 7: 143155, 2021 10.1159/000510455 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Goicoechea M, Rivera F, López-Gómez JM; Spanish Registry of Glomerulonephritis: Increased prevalence of acute tubulointerstitial nephritis. Nephrol Dial Transplant 28: 112115, 2013 10.1093/ndt/gfs143 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Zhang X, Donnan PT, Bell S, Guthrie B: Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol 18: 256, 2017 10.1186/s12882-017-0673-8 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Al-Aly Z, Maddukuri G, Xie Y: Proton pump inhibitors and the kidney: Implications of current evidence for clinical practice and when and how to deprescribe. Am J Kidney Dis 75: 497507, 2020 10.1053/j.ajkd.2019.07.012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Morales-Alvarez MC: Nephrotoxicity of antimicrobials and antibiotics. Adv Chronic Kidney Dis 27: 3137, 2020 10.1053/j.ackd.2019.08.001 PubMed

  • 7.

    Bagchi S, Yuan R, Engleman EG: Immune checkpoint inhibitors for the treatment of cancer: Clinical impact and mechanisms of response and resistance. Annu Rev Pathol 16: 223249, 2021 10.1146/annurev-pathol-042020-042741 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Martins F, Sofiya L, Sykiotis GP, Lamine F, Maillard M, Fraga M, et al.: Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat Rev Clin Oncol 16: 563580, 2019 10.1038/s41571-019-0218-0 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Cortazar FB, Kibbelaar ZA, Glezerman IG, Abudayyeh A, Mamlouk O, Motwani SS, et al.: Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: A multicenter study. J Am Soc Nephrol 31: 435446, 2020 10.1681/ASN.2019070676 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Gupta S, Short SAP, Sise ME, Prosek JM, Madhavan SM, Soler MJ, et al.; ICPi-AKI Consortium Investigators: Acute kidney injury in patients treated with immune checkpoint inhibitors. J Immunother Cancer 9: e003467, 2021 10.1136/jitc-2021-003467 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Zhou XJ, Su T, Xie J, Xie QH, Wang L-Z, Hu Y, et al. Genome-wide association study in acute tubulointerstitial nephritis. J Am Soc Nephrol 34: 895908, 2023.

  • 12.

    Murakami N, Mulvaney P, Danesh M, Abudayyeh A, Diab A, Abdel-Wahab N, et al; Immune Checkpoint Inhibitors in Solid Organ Transplant Consortium: A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant. Kidney Int 100: 196205, 2021 10.1016/j.kint.2020.12.015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Nguyen LS, Ortuno S, Lebrun-Vignes B, Johnson DB, Moslehi JJ, Hertig A, et al.: Transplant rejections associated with immune checkpoint inhibitors: A pharmacovigilance study and systematic literature review. Eur J Cancer 148: 3647, 2021 10.1016/j.ejca.2021.01.038 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Hoxha E, Wiech T, Stahl PR, Zahner G, Tomas NM, Meyer-Schwesinger C, et al.: A mechanism for cancer-associated membranous nephropathy. N Engl J Med 374: 19951996, 2016 10.1056/NEJMc1511702 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Kohatsu K, Suzuki T, Takimoto M, Matsui K, Hashiguchi A, Koike J, et al.: Granulomatous interstitial nephritis with CTLA-4 haploinsufficiency: A case report. BMC Nephrol 23: 367, 2022 10.1186/s12882-022-02999-x PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al.: Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med 20: 14101416, 2014 10.1038/nm.3746 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Dolladille C, Ederhy S, Sassier M, Cautela J, Thuny F, Cohen AA, et al.: Immune checkpoint inhibitor rechallenge after immune-related adverse events in patients with cancer. JAMA Oncol 6: 865871, 2020 10.1001/jamaoncol.2020.0726 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Jang HN, Jung S, Lee S, Chang SH, Lee TW, Bae E, et al.: Acute interstitial nephritis associated with ingestion of Achyranthes japonica extract: A case report. BMC Nephrol 22: 121, 2021 10.1186/s12882-021-02326-w PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    D’Errico S, Zanon M, Radaelli D, Concato M, Padovano M, Scopetti M, et al.: Acute kidney injury (AKI) in young synthetic cannabinoids abusers. Biomedicines 10: 1936, 2022 10.3390/biomedicines10081936 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Jayasumana C, Orantes C, Herrera R, Almaguer M, Lopez L, Silva LC, et al.: Chronic interstitial nephritis in agricultural communities: A worldwide epidemic with social, occupational and environmental determinants. Nephrol Dial Transplant 32: 234241, 2017 10.1093/ndt/gfw346 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Vervaet BA, Nast CC, Jayasumana C, Schreurs G, Roels F, Herath C, et al.: Chronic interstitial nephritis in agricultural communities is a toxin-induced proximal tubular nephropathy. Kidney Int 97: 350369, 2020 10.1016/j.kint.2019.11.009 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Kolli RT, Gunasekara SC, Foster MW, Adduri S, Strasma A, Wyatt C, et al.: The urinary proteome infers dysregulation of mitochondrial, lysosomal, and protein reabsorption processes in chronic kidney disease of unknown etiology (CKDu). Am J Physiol Renal Physiol 324: F387F403, 2023 10.1152/ajprenal.00285.2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23.

    Wijkström J, Elinder CG, Hultenby K, Söderberg M, Wernerson A: “Dysmorphic” lysosomes in proximal tubular cells are not specific for CINAC/CKDu and do not provide evidence that CINAC/CKDu is a toxin-induced disease. Kidney Int 98: 786787, 2020 10.1016/j.kint.2020.04.057 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Wesseling C: Is an environmental nephrotoxin the primary cause of CKDu (Mesoamerican Nephropathy)? CON. Kidney360 1: 596601, 2020 10.34067/KID.0002922020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Garnier AS, Dellamaggiore J, Brilland B, Lagarce L, Abgueguen P, Furber A, et al.: High incidence of amoxicillin-induced crystal nephropathy in patients receiving high dose of intravenous amoxicillin. J Clin Med 9: 2022, 2020 10.3390/jcm9072022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Jamme M, Oliver L, Ternacle J, Lepeule R, Moussafeur A, Haymann JP, et al.: Amoxicillin crystalluria is associated with acute kidney injury in patients treated for acute infective endocarditis. Nephrol Dial Transplant 36: 19551958, 2021 10.1093/ndt/gfab074 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27.

    Luque Y, Louis K, Jouanneau C, Placier S, Esteve E, Bazin D, et al.: Vancomycin-associated cast nephropathy. J Am Soc Nephrol 28: 17231728, 2017 10.1681/ASN.2016080867 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    Tantranont N, Luque Y, Hsiao M, Haute C, Gaber L, Barrios R, et al.: Vancomycin-associated tubular casts and vancomycin nephrotoxicity. Kidney Int Rep 6: 19121922, 2021 10.1016/j.ekir.2021.04.035 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29.

    Perazella MA: Vancomycin should be considered a nephrotoxic antimicrobial agent: Commentary. Kidney360 3: 14911493, 2022 10.34067/KID.0008112021 PubMed

  • 30.

    Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al; DELIVER Trial Committees and Investigators: Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 387: 10891098, 2022 10.1056/NEJMoa2206286 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31.

    Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al; DAPA-CKD Trial Committees and Investigators: Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 383: 14361446, 2020 10.1056/NEJMoa2024816 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32.

    Konta Y, Saito E, Sato K, Furuta K, Miyauchi K, Furukawa A, et al.: Tubulointerstitial nephritis after using a sodium-glucose cotransporter 2 inhibitor. Intern Med 61: 32393243, 2022 10.2169/internalmedicine.9011-21 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33.

    Ryan R, Choo S, Willows J, Walker J, Prasad K, Tez D: Acute interstitial nephritis due to sodium-glucose co-transporter 2 inhibitor empagliflozin. Clin Kidney J 14: 10201022, 2020 10.1093/ckj/sfaa033 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34.

    Yan MM, Zhao H, Li ZR, Chow JW, Zhang Q, Qi YP, et al.: Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS. Front Pharmacol 13: 921760, 2022 10.3389/fphar.2022.921760 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35.

    Luo H, Li X, Ren Q, Zhou Y, Chen G, Zhao B, et al. Acute kidney injury after COVID-19 vaccines: A real-world study. Ren Fail 44: 958965. 2022 10.1080/0886022X.2022.2081180

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36.

    Avramescu M, Isnard P, Temmam S, Chevalier A, Bastard P, Attia M, et al.: Acute tubulointerstitial nephritis with or without uveitis: A novel form of post-acute COVID-19 syndrome in children. Kidney Int 103: 11931198, 2023 10.1016/j.kint.2023.02.028 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37.

    Muriithi AK, Leung N, Valeri AM, Cornell LD, Sethi S, Fidler ME, et al.: Clinical characteristics, causes and outcomes of acute interstitial nephritis in the elderly. Kidney Int 87: 458464, 2015 10.1038/ki.2014.294 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    Muriithi AK, Nasr SH, Leung N: Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol 8: 18571862, 2013 10.2215/CJN.01330213 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39.

    Moledina DG, Eadon MT, Calderon F, Yamamoto Y, Shaw M, Perazella MA, et al.: Development and external validation of a diagnostic model for biopsy-proven acute interstitial nephritis using electronic health record data. Nephrol Dial Transplant 37: 22142222, 2022 10.1093/ndt/gfab346 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40.

    Moledina DG, Wilson FP, Pober JS, et al. Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis. JCI Insight 4: e127456, 2019 10.1172/jci.insight.127456

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41.

    Fernandez-Juarez G, Perez JV, Caravaca-Fontán F, Quintana L, Shabaka A, Rodriguez E, et al; Spanish Group for the Study of Glomerular Diseases (GLOSEN): Duration of treatment with corticosteroids and recovery of kidney function in acute interstitial nephritis. Clin J Am Soc Nephrol 13: 18511858, 2018 10.2215/CJN.01390118 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42.

    Prendecki M, Tanna A, Salama AD, Tam FW, Cairns T, Taube D, et al.: Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids. Clin Kidney J 10: 233239, 2017 10.1093/ckj/sfw116 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43.

    Mose FH, Birn H, Hoffmann-Petersen N, Bech JN: Prednisolone treatment in acute interstitial nephritis (PRAISE) - protocol for the randomized controlled trial. BMC Nephrol 22: 161, 2021 10.1186/s12882-021-02372-4 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44.

    Casals J, Acosta Y, Caballero G, Morantes L, Zamora C, Xipell M, et al.: Differentiating acute interstitial nephritis from immune checkpoint inhibitors from other causes. Kidney Int Rep 8: 672675, 2022 10.1016/j.ekir.2022.12.017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 45.

    Arbour KC, Mezquita L, Long N, Rizvi H, Auclin E, Ni A, et al.: Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer. J Clin Oncol 36: 28722878, 2018 10.1200/JCO.2018.79.0006 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46.

    Herrmann SM: Is rechallenge appropriate in patients that develop immune checkpoint inhibitor-associated AKI?: PRO. Kidney360 3: 799802, 2021 10.34067/KID.0003962021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47.

    Allouchery M, Lombard T, Martin M, Rouby F, Sassier M, Bertin C, et al; French Network of Regional Pharmacovigilance Centers: Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer. J Immunother Cancer 8: e001622, 2020 10.1136/jitc-2020-001622 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48.

    Chennamadhavuni A, Abushahin L, Jin N, Presley CJ, Manne A: Risk factors and biomarkers for immune-related adverse events: A practical guide to identifying high-risk patients and rechallenging immune checkpoint inhibitors. Front Immunol 13: 779691, 2022 10.3389/fimmu.2022.779691 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 49.

    Kanduri SR, Velez JCQ: Is rechallenge appropriate in patients that develop immune checkpoint inhibitor-associated AKI?: CON. Kidney360 3: 803805, 2021 10.34067/KID.0003902021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50.

    Chatzidionysiou K, Liapi M, Tsakonas G, Gunnarsson I, Catrina A: Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift? Clin Rheumatol 40: 16871695, 2021 10.1007/s10067-020-05420-w PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51.

    Stroud CR, Hegde A, Cherry C, Naqash AR, Sharma N, Addepalli S, et al.: Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade. J Oncol Pharm Pract 25: 551557, 2019 10.1177/1078155217745144 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 664 665 208
Full Text Views 515 515 33
PDF Downloads 723 723 46